A study of the effects of dexametasone versus intensive hydration on nausea and vomiting after tonsillectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201010141936N5

Enrollment

Registered

2010-10-18

Start date

2010-10-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting. -

Interventions

Intervention 1: Control group: all patients will receive dexamethasone 0.5 mg/kg before the end of surgery. Intervention 2: Intervention group: all patients will receive 30 cc/kg ringer solution befor

Prevention

Control group: all patients will receive dexamethasone 0.5 mg/kg before the end of surgery

Intervention group: all patients will receive 30 cc/kg ringer solution before induction and during the operation

Eligibility

Sex/Gender

All

Age

5 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients who are candidate for elective tonsillectomy and signed the consent form will be recruited. Exclusion criteria: history of renal disease, hepatic disease, cardiovascular and respiratory disease and history of previous nausea and vomiting.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Post operative nausea and vomitting. Timepoint: 90 minute. Method of measurement: observation.	—

Secondary

Measure	Time frame
Post operative pain. Timepoint: 90 minute. Method of measurement: Analogous pain score.;Shivering. Timepoint: 90 minute. Method of measurement: Observation.;Supplemental analgesic drugs. Timepoint: 90 minute. Method of measurement: medical chart.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026